CRP and prostate carcinoma: Third, CRP is only one of the inflammatory markers, and a recent study has reported that genetically predicted circulating concentrations of several inflammatory-related cytokines were associated with the risk of breast, endometrial, lung, ovarian, and prostate cancer [39].